Association between COVID-19 diagnosis and postoperative outcomes in sleeve gastrectomy and Roux-en-Y gastric bypass: A national cohort study - 18/03/24
Abstract |
Background |
We seek to determine the association between COVID-19 diagnosis and postoperative outcomes following bariatric surgery.
Methods |
Using the Metabolic and Bariatric Surgery Accreditation Quality Improvement Project (MBSAQIP) database, patients undergoing sleeve gastrectomy and gastric bypass without a COVID-19 diagnosis were 2:1 propensity-score matched to those with COVID-19 infection pre or postoperatively.
Results |
1369 (0.74 %) and 1331 (0.72 %) patients had a COVID-19 diagnosis within 14 days prior to or 30 days after their operation, respectively. Patients with preoperative COVID-19 infection had equivalent outcomes to COVID-19 negative patients (all p > 0.05). Postoperative COVID-19 diagnosis was associated with worse outcomes including increased risk of anastomotic/staple line leak (1.1 % vs 0.1 %, p < 0.001), postoperative pneumonia (2.9 % vs 0.1 %, p < 0.001), and 30-day reoperation (2.1 % vs 0.9 %, p = 0.002).
Conclusions |
Postoperative diagnosis of COVID-19 after bariatric surgery is associated with worse outcomes; however, it is safe to perform these procedures on patients recently convalesced from COVID-19 infection.
Le texte complet de cet article est disponible en PDF.Highlights |
• | COVID-19 diagnosis within 14 days before SG or RYGB was not associated with an increase in postoperative complications. |
• | Diagnosis of COVID-19 within 30 days following SG and RYGB is associated with worse outcomes, including anastomotic leak. |
• | Patients undergoing SG and RYGB were propensity matched to assess the effect of pre and post operative diagnosis of COVID-19. |
Plan
Vol 230
P. 43-46 - avril 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.